Current Drug Targets

95.1k citations
3.0k papers · · active since 1950

Impact in

Papers in

Current Drug Targets

2.7k papers receiving 87.5k citations

Peers

Current Drug Targets
Comparison fields: 5 of 219
  • Biological Psychiatry 1.7k
  • Molecular Biology 36.9k
  • Cancer Research 7.4k
  • Molecular Medicine 2.6k
  • Pharmacology 6.7k
Replace Expert Opinion on Investigational Drugs with:
Expert Opinion on Investigational Drugs United States
Free Radical Research Japan
Journal of Internal Medicine Sweden
Current Opinion in Pharmacology United States
Drug Design Development and Therapy China
Current Topics in Medicinal Chemistry United States
Acta Pharmacologica Sinica China
The Journal of Nutritional Biochemistry United States
Journal of Biomedical Science Taiwan
Acta Pharmaceutica Sinica B China
Current Drug Targets relative to Expert Opinion on Investigational Drugs United States Expert Opinion on Investigational Drugs's profile →
Citations per field
00.5×1.5×
Expert Opinion on Investigational Drugs · 1×
Citations per year

Countries where authors publish in Current Drug Targets

Since Specialization
Citations

This map shows the geographic impact of research published in Current Drug Targets. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Current Drug Targets with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Current Drug Targets more than expected).

Fields of papers published in Current Drug Targets

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Current Drug Targets. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Current Drug Targets.

About Current Drug Targets

The 3.0k papers published in Current Drug Targets in the last decades have received a total of 95.1k indexed citations . Papers published in Current Drug Targets usually cover Molecular Biology (1.1k papers), Oncology (379 papers), Cancer Research (204 papers), Molecular Medicine (71 papers) and Pharmacology (210 papers) specifically the topics of Computational Drug Discovery Methods (113 papers), Inflammatory Bowel Disease (91 papers), RNA Interference and Gene Delivery (71 papers), Nanoparticle-Based Drug Delivery (62 papers), Receptor Mechanisms and Signaling (53 papers), Cholinesterase and Neurodegenerative Diseases (51 papers), MicroRNA in disease regulation (49 papers) and Neuroscience and Neuropharmacology Research (45 papers). The most active scholars publishing in Current Drug Targets are Walter Filgueira de Azevedo, Thomas Efferth, Firas Baidoun, Manikandan Palrasu, Siddavaram Nagini, Nikolaus Seiler, Michael F. Holick, Craig A. Stockmeier, Grażyna Rajkowska and Irmgard Merfort.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact